Medically reviewed by Marla Anderson, MD Multiple myeloma is a type of blood cancer that forms in plasma cells, white blood ...

Throughout my experience with multiple myeloma, I was humbled by the unexpected support and kindness shown to me.

Researchers sought to determine whether teclistamab would lead to a clinical response in patients with relapsed/refractory multiple myeloma.

Researchers discover that bone marrow cancer cells diversify drastically when exiting the bone marrow, which also affects the ...

Jan. 14, 2025 — A team of researchers has developed a new biomaterial with high potential in in the treatment of bone lesions or minimal residual disease in multiple myeloma patients.

On the basis of the data presented from the MM-009 and MM-010 trials, FDA approved lenalidomide for use in combination with dexamethasone in patients with MM who have received one prior therapy ...

The U.S. Department of Agriculture’s Food Safety and Inspection Service (FSIS) has issued a public health alert over concerns that some packages may contain bone fragments. The alert, issued Jan. 27, ...

fewer patients in the left TRA group exhibited DWI lesions on the contralateral side of the carotid lesion. All carotid stenoses were successfully dilated. Except for one patient in the right TRA ...

It’s a brittle bone disease that’s inherited,” Hemmesch said. It’s an especially cruel condition for a young man working on his parent’s farm. “One time, all I did was reach up to the ...

It’s a brittle bone disease that’s inherited,” Hemmesch said. It’s an especially cruel condition for a young man working on his parent’s farm. “One time, all I did was reach ... the mailroom became ...